Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0034063 (pulmonary edema)
 10,665 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Detailed hemodynamic, metabolic and blood volume studies were performed in a patient with hydatidiform mole who developed pulmonary edema associated with a high cardiac output. Several factors including hyperthyroidism, hypervolemia, and the molar state probably contributed to the left ventricular failure in this patient. results of these studies suggest that patients with hydatidiform mole and pulmonary edema need correction of the hypervolemia as well as removal of the molar tissue.
 ...
PMID:High output heart failure associated with pulmonary edema complicating hydatidiform mole. 55 15

We experienced a case of myocardial infarction associated with pulmonary edema in a patient with hydatidiform mole probably due to methylergometrin and prostaglandin F2 alpha (PGF2 alpha) administered during the operation. A 26-year-old woman was scheduled to have curettage for hydatidiform mole under general anesthesia. She had no previous history of cardiopulmonary disease. During the operation, 0.4 mg of methylergometrin was administered intravenously to induce uterine contraction. Because the contraction was not sufficient, 2 mg of PGF2 alpha was given into the uterine muscle. A few minutes later blood pressure and heart rate increased abruptly and arterial blood gas analysis showed hypoxia and respiratory acidosis. Pulmonary edema was confirmed by chest X-P. After ordinary treatment for pulmonary edema, she was transferred to ICU. Postoperative examinations of ECG, serum enzymes and echocardiography revealed anterior subendocardial infarction. About one month later, methylergometrin test was performed during coronary angiography and this induced coronary vasospasm. PGF2 alpha is also known to cause peripheral as well as pulmonary vasoconstriction. Acute myocardial infarction induced by methylergometrin and PGF2 alpha may be a possible cause of this episode.
 ...
PMID:[A case of myocardial infarction associated with pulmonary edema during curettage for hydatidiform mole]. 205 64

Cardiopulmonary dysfunction has been observed after the removal of benign hydatidiform mole. Of 60 cases reviewed with benign trophoblastic disease, five developed respiratory complications. Two patients developed pulmonary edema that progressed to adult respiratory distress syndrome. Autopsy of two patients showed no evidence of pulmonary trophoblastic emboli. Possible etiologies for the pulmonary findings, including trophoblastic emboli, hypervolemia, disseminated intravascular coagulation, and hyperthyroidism, are discussed.
 ...
PMID:Benign molar pregnancies: pulmonary complications. 697 15

Hydatid mole with a coexisting pregnancy is rare and presents a high risk for maternal and fetal morbidity and mortality. A case of hydatid mole with coexisting pregnancy that progressed to 24 weeks' gestation is presented. Maternal religious beliefs regarding pregnancy termination affected the medical plan of care. Although the woman was aware of the potential complications, pregnancy termination and karyotype testing were refused. Because of uncontrollable hemorrhage, a cesarean delivery was done. The genotypically normal fetus died 10 hours after birth. After delivery, preeclampsia, pulmonary edema, and renal failure developed in the woman, which resolved within 4 days.
 ...
PMID:Hydatid mole with a coexisting pregnancy. 897 88

A complete hydatidiform mole coexisting with a fetus is a rare condition. The diagnosis is often difficult because of the morphological similarity to a partial mole, but is crucial to management in the postmolar course. We present a case of molar pregnancy coexisting with a fetus in which DNA polymorphism analysis revealed a different genetic origin for the fetal and molar parts. This is the only known case of a complete mole in a twin pregnancy complicated by pre-eclampsia followed by maternal pulmonary oedema. During follow-up, the patient developed a clinically invasive mole which was successfully treated with chemotherapy. In this case, genetic analysis unequivocally diagnosed a twin pregnancy consisting of a complete hydatidiform mole and a fetus.
 ...
PMID:DNA polymorphism analysis of a case of complete hydatidiform mole coexisting with a fetus. 943 8

A triplet pregnancy in a 23-year-old woman was terminated at 15 weeks of gestation because of her severe hypertension, lung edema, and secondary hyperthyroidism. The pregnancy consisted of a hydatidiform mole with a 46,XY karyotype and two fetuses each with 46,XX and a 46,XY karyotype. To determine the zygosity and genetic origin of the mole and fetuses, PCR- and computer-assisted genotyping were performed at 27 CA-repeat marker loci that were distributed evenly over the genome. As a result, genotypes of the three pregnancy products were distinct from each other, indicating that the triplets were trizygotic. The mole lacked any maternal alleles but inherited both of the paternal alleles and/or one paternal allele in duplicate. This, along with the XY sex chromosome constitution, indicated that the mole resulted from dispermic androgenesis. The mother developed a persistent trophoblastic tumor thereafter.
 ...
PMID:Trizygotic pregnancy consisting of two fetuses and a complete hydatidiform mole with dispermic androgenesis. 991 46